{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T15:08:15Z","timestamp":1778944095895,"version":"3.51.4"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["KE 2179\/2-1"],"award-info":[{"award-number":["KE 2179\/2-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["TS 303\/2-1"],"award-info":[{"award-number":["TS 303\/2-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002839","name":"Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002839","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017268","name":"Berlin Institute of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003042","name":"Else Kr\u00f6ner-Fresenius-Stiftung","doi-asserted-by":"publisher","award":["EKFS 2017_A22"],"award-info":[{"award-number":["EKFS 2017_A22"]}],"id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.bone.2020.115646","type":"journal-article","created":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T11:38:57Z","timestamp":1600083537000},"page":"115646","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Effects of CGRP receptor antagonism on glucose and bone metabolism in mice with diet-induced obesity"],"prefix":"10.1016","volume":"143","author":[{"given":"Paul","family":"K\u00f6hli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessika","family":"Appelt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen","family":"Otto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise","family":"Jahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anke","family":"Baranowsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alina","family":"Bahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cordula","family":"Erdmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith","family":"M\u00fcchler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"M\u00fclleder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serafeim","family":"Tsitsilonis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Keller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2020.115646_bb0005","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/head.13301","article-title":"Migraine burden of disease: from the patient's experience to a socio-economic view","volume":"58","author":"Agosti","year":"2018","journal-title":"Headache: The Journal of Head and Face Pain. Blackwell Publishing Inc."},{"issue":"1","key":"10.1016\/j.bone.2020.115646_bb0010","doi-asserted-by":"crossref","DOI":"10.1186\/s10194-019-0993-0","article-title":"A narrative review on the burden of migraine: when the burden is the impact on people's life","volume":"20","author":"Leonardi","year":"2019","journal-title":"Journal of Headache and Pain"},{"key":"10.1016\/j.bone.2020.115646_bb0015","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/S0140-6736(19)32504-8","article-title":"Targeting calcitonin gene-related peptide: a new era in migraine therapy","author":"Charles","year":"2019","journal-title":"The Lancet"},{"key":"10.1016\/j.bone.2020.115646_bb0020","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41582-018-0003-1","article-title":"CGRP as the target of new migraine therapies - successful translation from bench to clinic","author":"Edvinsson","year":"2018","journal-title":"Nature Reviews Neurology"},{"key":"10.1016\/j.bone.2020.115646_bb0025","article-title":"Molecular studies of CGRP and the CGRP family of peptides in the central nervous system","author":"Hendrikse","year":"2018","journal-title":"Cephalalgia"},{"issue":"1","key":"10.1016\/j.bone.2020.115646_bb0030","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0306-4522(88)90018-8","article-title":"\u2018Differential expression of \u03b1-CGRP and \u03b2-CGRP by primary sensory neurons and enteric autonomic neurons of the rat\u2019, Neuroscience","volume":"25","author":"Muddhrry","year":"1988","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.bone.2020.115646_bb0035","first-page":"170","article-title":"\u2018Enteric and visceral afferent CGRP neurons: targets of innervation and differential expression patterns\u2019, Annals of the New York Academy of Sciences","volume":"657","author":"Sternini","year":"1992","journal-title":"John Wiley & Sons, Ltd"},{"issue":"5","key":"10.1016\/j.bone.2020.115646_bb0040","first-page":"384","article-title":"\u2018Vasoactive peptide levels in the plasma of young migraine patients with and without Aura assessed both Interictally and Ictally\u2019, Cephalalgia","volume":"15","author":"Gallai","year":"1995","journal-title":"SAGE Publications"},{"issue":"2","key":"10.1016\/j.bone.2020.115646_bb0045","first-page":"193","article-title":"\u2018Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system\u2019, Annals of Neurology","volume":"23","author":"Goadsby","year":"1988","journal-title":"John Wiley & Sons, Ltd"},{"issue":"2","key":"10.1016\/j.bone.2020.115646_bb0050","first-page":"183","article-title":"\u2018Vasoactive peptide release in the extracerebral circulation of humans during migraine headache\u2019, Annals of Neurology","volume":"28","author":"Goadsby","year":"1990","journal-title":"John Wiley & Sons, Ltd"},{"issue":"11","key":"10.1016\/j.bone.2020.115646_bb0055","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/0028-3908(91)90165-8","article-title":"Dihydroergotamine and sumatriptan attenuate levels of CGRP in plasma in rat superior sagittal sinus during electrical stimulation of the trigeminal ganglion","volume":"30","author":"Buzzi","year":"1991","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.bone.2020.115646_bb0060","first-page":"93","article-title":"\u2018Trigeminal ganglion stimulation increases facial skin blood flow in the rat: a major role for calcitonin gene-related peptide\u2019, Brain Research","volume":"669","author":"Escott","year":"1995","journal-title":"Elsevier"},{"issue":"3","key":"10.1016\/j.bone.2020.115646_bb0065","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1365-2125.1989.tb05424.x","article-title":"A comparison of the effects of human alpha calcitonin gene-related peptide and glyceryl trinitrate on regional blood velocity in man","volume":"28","author":"MacDonald","year":"1989","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1016\/j.bone.2020.115646_bb0070","first-page":"bph.14988","article-title":"100 years of modelling ligand-receptor binding and response: a focus on GPCRs","author":"Finlay","year":"2020","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.bone.2020.115646_bb0075","series-title":"\u2018Blocking CGRP in Migraine Patients \u2013 A Review of Pros and Cons\u2019, Journal of Headache and Pain","first-page":"96","author":"Deen","year":"2017"},{"key":"10.1016\/j.bone.2020.115646_bb0080","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/head.13379","article-title":"History and review of anti-calcitonin gene-related peptide (CGRP) therapies: from translational research to treatment","volume":"58","author":"Tepper","year":"2018","journal-title":"Headache: The Journal of Head and Face Pain. Blackwell Publishing Inc."},{"issue":"19","key":"10.1016\/j.bone.2020.115646_bb0085","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1001\/jama.2019.16711","article-title":"Effect of ubrogepant vs placebo on pain and the most bothersome associated symptom in the acute treatment of migraine: the achieve ii randomized clinical trial","volume":"322","author":"Lipton","year":"2019","journal-title":"JAMA - Journal of the American Medical Association"},{"key":"10.1016\/j.bone.2020.115646_bb0090","first-page":"1","article-title":"Ubrogepant: first approval","author":"Scott","year":"2020","journal-title":"Drugs"},{"issue":"9","key":"10.1016\/j.bone.2020.115646_bb0095","first-page":"1597","article-title":"\u2018Novel medications for the treatment of migraine\u2019, Headache: The Journal of Head and Face Pain","volume":"59","author":"Ceriani","year":"2019","journal-title":"Blackwell Publishing Inc."},{"issue":"1","key":"10.1016\/j.bone.2020.115646_bb0100","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1476-5381.2011.01525.x","article-title":"Calcitonin and calcitonin receptor-like receptors: common themes with family B GPCRs","volume":"166","author":"Barwell","year":"2012","journal-title":"British Journal of Pharmacology"},{"issue":"1","key":"10.1016\/j.bone.2020.115646_bb0105","first-page":"3","article-title":"\u2018Update on the pharmacology of calcitonin\/CGRP family of peptides: IUPHAR review 25\u2019, British Journal of Pharmacology","volume":"175","author":"Hay","year":"2018","journal-title":"John Wiley and Sons Inc."},{"key":"10.1016\/j.bone.2020.115646_bb0110","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1152\/physrev.00034.2013","article-title":"Calcitonin gene-related peptide: physiology and pathophysiology","author":"Russell","year":"2014","journal-title":"Physiological reviews"},{"issue":"3","key":"10.1016\/j.bone.2020.115646_bb0115","first-page":"469","article-title":"\u2018Distribution of CGRP-, VIP-, D\u03b2H-, SP-, and NPY-immunoreactive nerves in the periosteum of the rat\u2019, Cell and Tissue Research","volume":"264","author":"Hill","year":"1991","journal-title":"Springer-Verlag"},{"issue":"2","key":"10.1016\/j.bone.2020.115646_bb0120","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/jemt.10122","article-title":"\u2018Calcitonin gene-related peptide (CGRP)-containing nerve fibers in bone tissue and their involvement in bone remodeling\u2019, Microscopy Research and Technique","volume":"58","author":"Irie","year":"2002","journal-title":"Microsc. Res. Tech."},{"issue":"12","key":"10.1016\/j.bone.2020.115646_bb0125","first-page":"2049","article-title":"\u2018Decreased bone formation and osteopenia in mice lacking \u03b1-calcitonin gene-related peptide\u2019, Journal of Bone and Mineral Research","volume":"19","author":"Schinke","year":"2004","journal-title":"John Wiley & Sons, Ltd"},{"issue":"4","key":"10.1016\/j.bone.2020.115646_bb0130","first-page":"861","article-title":"\u2018Calcitonin gene-related peptide in human obesity\u2019, Peptides","volume":"12","author":"Zelissen","year":"1991","journal-title":"Elsevier"},{"issue":"2","key":"10.1016\/j.bone.2020.115646_bb0135","first-page":"343","article-title":"\u2018Plasma level of calcitonin gene-related peptide in patients with polycystic ovary syndrome and its relationship to hormonal and metabolic parameters\u2019, Peptides","volume":"34","author":"Zhang","year":"2012","journal-title":"Elsevier"},{"issue":"6","key":"10.1016\/j.bone.2020.115646_bb0140","doi-asserted-by":"crossref","first-page":"e0180547","DOI":"10.1371\/journal.pone.0180547","article-title":"Differential effects of Calca-derived peptides in male mice with diet-induced obesity","volume":"12","author":"Bartelt","year":"2017","journal-title":"PLOS ONE"},{"issue":"2","key":"10.1016\/j.bone.2020.115646_bb0145","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.cmet.2019.12.012","article-title":"Calcitonin receptor neurons in the mouse nucleus Tractus solitarius control energy balance via the non-aversive suppression of feeding","volume":"31","author":"Cheng","year":"2020","journal-title":"Cell Metabolism"},{"issue":"5","key":"10.1016\/j.bone.2020.115646_bb0150","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1210\/en.2016-1510","article-title":"\u2018Endogenous calcitonin gene-related peptide regulates lipid metabolism and energy homeostasis in male mice\u2019, Endocrinology","volume":"158","author":"Liu","year":"2017","journal-title":"Endocrine Society"},{"issue":"21","key":"10.1016\/j.bone.2020.115646_bb0155","doi-asserted-by":"crossref","DOI":"10.21037\/atm.2017.08.27","article-title":"Calcitonin gene-related peptide: neuroendocrine communication between the pancreas, gut, and brain in regulation of blood glucose","volume":"5","author":"Pendharkar","year":"2017","journal-title":"Annals of Translational Medicine"},{"key":"10.1016\/j.bone.2020.115646_bb0160","series-title":"\u2018Animal Models in Bone Research\u2019, in","first-page":"129","author":"Kimmel","year":"2017"},{"issue":"SUPPL.58","key":"10.1016\/j.bone.2020.115646_bb0165","article-title":"Overview of animal models of obesity","author":"Lutz","year":"2012","journal-title":"Current Protocols in Pharmacology"},{"issue":"3","key":"10.1016\/j.bone.2020.115646_bb0170","first-page":"162","article-title":"\u2018Animal modeling in bone research\u2014should we follow the white rabbit?\u2019, Animal Models and Experimental Medicine","volume":"2","author":"Schafrum Macedo","year":"2019","journal-title":"Wiley"},{"key":"10.1016\/j.bone.2020.115646_bb0175","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1177\/0023677213501659","article-title":"Fasting of mice: a review","author":"Jensen","year":"2013","journal-title":"Laboratory Animals"},{"issue":"10","key":"10.1016\/j.bone.2020.115646_bb0180","article-title":"\u2018The 3Rs and humane experimental technique: implementing change\u2019, Animals","volume":"9","author":"Hubrecht","year":"2019","journal-title":"MDPI AG"},{"key":"10.1016\/j.bone.2020.115646_bb0185","author":"GV-SOLAS"},{"issue":"13","key":"10.1016\/j.bone.2020.115646_bb0190","doi-asserted-by":"crossref","first-page":"500","DOI":"10.5694\/j.1326-5377.1960.tb73127.x","article-title":"The principles of humane experimental technique","volume":"1","author":"Russell","year":"1960","journal-title":"Med. J. Aust."},{"issue":"4","key":"10.1016\/j.bone.2020.115646_bb0195","first-page":"661","article-title":"\u2018The effect of traumatic brain injury on bone healing: an experimental study in a novel in vivo animal model\u2019, Injury","volume":"46","author":"Tsitsilonis","year":"2015","journal-title":"Elsevier Ltd"},{"issue":"1","key":"10.1016\/j.bone.2020.115646_bb0200","first-page":"911","article-title":"\u2018A rapid method of total lipid extraction and purification\u2019, Canadian Journal of Biochemistry and Physiology","volume":"37","author":"Bligh","year":"1959","journal-title":"Canadian Science Publishing"},{"key":"10.1016\/j.bone.2020.115646_bb0205","series-title":"Methods in Molecular Biology","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/978-1-4939-6747-6_23","article-title":"Data conversion with proteoWizard msConvert","author":"Adusumilli","year":"2017"},{"issue":"4","key":"10.1016\/j.bone.2020.115646_bb0210","first-page":"672","article-title":"\u2018Loss of menin in osteoblast lineage affects osteocyte-osteoclast crosstalk causing osteoporosis\u2019, Cell Death and Differentiation","volume":"24","author":"Liu","year":"2017","journal-title":"Nat. Publ. Group"},{"issue":"330","key":"10.1016\/j.bone.2020.115646_bb0215","doi-asserted-by":"crossref","first-page":"330ra37","DOI":"10.1126\/scitranslmed.aad8996","article-title":"Chronic skin inflammation leads to bone loss by IL-17-mediated inhibition of Wnt signaling in osteoblasts","volume":"8","author":"Ulu\u00e7kan","year":"2016","journal-title":"Science Translational Medicine"},{"issue":"6","key":"10.1016\/j.bone.2020.115646_bb0220","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1023\/B:BILE.0000019559.84305.47","article-title":"Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: BestKeeper\u2013Excel-based tool using pair-wise correlations","volume":"26","author":"Pfaffl","year":"2004","journal-title":"Biotechnology letters"},{"issue":"1","key":"10.1016\/j.bone.2020.115646_bb0225","first-page":"1","article-title":"\u2018Undecalcified preparation of bone tissue: report of technical experience and development of new methods\u2019, Virchows Archiv A Pathological Anatomy and Histopathology","volume":"418","author":"Hahn","year":"1991","journal-title":"Springer-Verlag"},{"issue":"466","key":"10.1016\/j.bone.2020.115646_bb0230","article-title":"\u2018Wnt1 is an Lrp5-independent bone-anabolic Wnt ligand\u2019, Science Translational Medicine","volume":"10","author":"Luther","year":"2018","journal-title":"American Association for the Advancement of Science"},{"issue":"1","key":"10.1016\/j.bone.2020.115646_bb0235","first-page":"2","article-title":"\u2018Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry nomenclature committee\u2019, Journal of Bone and Mineral Research","volume":"28","author":"Dempster","year":"2013","journal-title":"John Wiley & Sons, Ltd"},{"issue":"4","key":"10.1016\/j.bone.2020.115646_bb0240","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3758\/BRM.41.4.1149","article-title":"Statistical power analyses using G*power 3.1: tests for correlation and regression analyses","volume":"41","author":"Erdfelder","year":"2009","journal-title":"Behav. Res. Methods"},{"key":"10.1016\/j.bone.2020.115646_bb0245","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2105-7-123","article-title":"Detecting outliers when fitting data with nonlinear regression - a new method based on robust nonlinear regression and the false discovery rate","volume":"7","author":"Motulsky","year":"2006","journal-title":"BMC Bioinformatics"},{"issue":"4","key":"10.1016\/j.bone.2020.115646_bb0250","first-page":"625","article-title":"\u2018CGRP and its receptors\u2019, Headache: The Journal of Head and Face Pain","volume":"57","author":"Hay","year":"2017","journal-title":"Blackwell Publishing Inc."},{"issue":"8","key":"10.1016\/j.bone.2020.115646_bb0255","first-page":"566","article-title":"Drug profile: olcegepant, a non-peptide CGRP1 antagonist for migraine treatment","volume":"10","author":"Recober","year":"2007","journal-title":"IDrugs"},{"issue":"9","key":"10.1016\/j.bone.2020.115646_bb0260","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1210\/en.2010-0284","article-title":"\u2018Mice lacking the neuropeptide \u03b1-calcitonin gene-related peptide are protected against diet-induced obesity\u2019, Endocrinology","volume":"151","author":"Walker","year":"2010","journal-title":"Endocrine Society"},{"issue":"2","key":"10.1016\/j.bone.2020.115646_bb0265","first-page":"E297","article-title":"\u2018Glucose-dependent insulinotropic polypeptide (GIP) induces calcitonin gene-related peptide (CGRP)-I and procalcitonin (pro-CT) production in human adipocytes\u2019, The Journal of Clinical Endocrinology & Metabolism","volume":"96","author":"Timper","year":"2011","journal-title":"Oxford Academic"},{"issue":"10","key":"10.1016\/j.bone.2020.115646_bb0270","first-page":"938","article-title":"\u2018Therapeutic effects and safety of olcegepant and telcagepant for migraine: a meta-analysis\u2019, Neural Regeneration Research","volume":"8","author":"Yao","year":"2013","journal-title":"Wolters Kluwer \u2013 Medknow Publications"},{"issue":"7","key":"10.1016\/j.bone.2020.115646_bb0275","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1359\/jbmr.1999.14.7.1067","article-title":"\u2018Targeted expression of calcitonin gene-related peptide to osteoblasts increases bone density in mice\u2019, Journal of Bone and Mineral Research","volume":"14","author":"Ballica","year":"1999","journal-title":"J. Bone Miner. Res."},{"issue":"3","key":"10.1016\/j.bone.2020.115646_bb0280","first-page":"701","article-title":"\u2018Calcitonin gene-related peptide (CGRP) inhibits apoptosis in human osteoblasts by \u03b2-catenin stabilization\u2019, Journal of Cellular Physiology","volume":"225","author":"Mrak","year":"2010","journal-title":"John Wiley & Sons, Ltd"},{"issue":"11","key":"10.1016\/j.bone.2020.115646_bb0285","first-page":"1467","article-title":"\u2018Calcitonin gene-related peptide stimulates BMP-2 expression and the differentiation of human osteoblast-like cells in vitro\u2019, Acta Pharmacologica Sinica","volume":"34","author":"Tian","year":"2013","journal-title":"Nat. Publ. Group"},{"issue":"5","key":"10.1016\/j.bone.2020.115646_bb0290","first-page":"1369","article-title":"\u2018Calcitonin-gene-related peptide stimulates stromal cell osteogenic differentiation and inhibits RANKL induced NF-\u03baB activation, osteoclastogenesis and bone resorption\u2019, Bone","volume":"46","author":"Wang","year":"2010","journal-title":"NIH Public Access"},{"issue":"6","key":"10.1016\/j.bone.2020.115646_bb0295","first-page":"4689","article-title":"\u2018Calcitonin gene-related peptide promotes the expression of osteoblastic genes and activates the WNT signal transduction pathway in bone marrow stromal stem cells\u2019, Molecular Medicine Reports","volume":"13","author":"Zhou","year":"2016","journal-title":"Spandidos Publications"},{"key":"10.1016\/j.bone.2020.115646_bb0300","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.abb.2008.02.013","article-title":"The role of calcitonin and \u03b1-calcitonin gene-related peptide in bone formation","author":"Huebner","year":"2008","journal-title":"Archives of Biochemistry and Biophysics"},{"issue":"5","key":"10.1016\/j.bone.2020.115646_bb0305","first-page":"383","article-title":"\u2018BIBN4096BS and CGRP8-37 antagonize the relaxant effects of \u03b1-CGRP more than those of \u03b2-CGRP in human extracranial arteries\u2019, Naunyn-Schmiedeberg's Archives of Pharmacology","volume":"371","author":"Verheggen","year":"2005","journal-title":"Springer"},{"issue":"1","key":"10.1016\/j.bone.2020.115646_bb0310","first-page":"78","article-title":"\u2018Glucagon-like peptide-1(GLP-1) receptor agonists: potential to reduce fracture risk in diabetic patients?\u2019, British Journal of Clinical Pharmacology","volume":"81","author":"Luo","year":"2016","journal-title":"Blackwell Publishing Ltd"},{"key":"10.1016\/j.bone.2020.115646_bb0315","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ejphar.2016.01.003","article-title":"Long acting analogue of the calcitonin gene-related peptide induces positive metabolic effects and secretion of the glucagon-like peptide-1","volume":"773","author":"Nilsson","year":"2016","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.bone.2020.115646_bb0320","doi-asserted-by":"crossref","DOI":"10.1124\/jpet.119.261065","article-title":"Characterization of ubrogepant: a potent and selective antagonist of the human calcitonin gene\u2013related peptide receptor*","author":"Moore","year":"2020","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.bone.2020.115646_bb0325","first-page":"264","article-title":"A potential preclinical migraine model: CGRP-sensitized mice","author":"Russo","year":"2009","journal-title":"Molecular and Cellular Pharmacology"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328220304269?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328220304269?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T14:15:09Z","timestamp":1778940909000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328220304269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":65,"alternative-id":["S8756328220304269"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2020.115646","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of CGRP receptor antagonism on glucose and bone metabolism in mice with diet-induced obesity","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2020.115646","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115646"}}